U.S. market Closed. Opens in 17 hours 16 minutes

ROIV | Roivant Sciences Ltd. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for ROIV we got that it has strong fundamentals where Valuation is considered to be fairly valued, Profitability is stunning wealthy, Growth is very good and Health is strong.

Valuation (57%)

Company Industry
P/E Ratio (TTM) 1.86 -15.40
PEG Ratio (TTM) 0.05 -1.28
P/S Ratio (TTM) 55.78 47.91
P/B Ratio (TTM) 1.62 21.47
P/FCF Ratio (TTM) -12.43 5.35
Price to 5YR AVG Earnings Ratio 15.00 -0.30
Price to 5YR AVG FCF Ratio -12.12 -7.28

Profitability (100%)

Company Industry
ROA (TTM) 72.90% -2.96%
ROE (TTM) 102.72% 23.42%
Net Profit Margin (TTM) 2,991.76% -894.56%
ROIC 5YR AVG 56.12% 16.62%

Growth (78%)

4QTR AVG 3YR AVG 5YR AVG
EPS 438.17% 31.98% 98.28%
Revenue 35.04% 960.04% 598.92%
Net Income 457.60% 12.53% 91.61%
Cash Flow -3.77% 10.13% 3.04%

Health (63%)

Company Industry
Current Ratio (TTM) 27.91 5.73
Quick Ratio (TTM) 27.75 5.45
D/E Ratio (TTM) 0.06 -14.53
Interest Coverage (TTM) 123.28 3.88
Piotroski F-Score 4 5
Altman Z-Score 12.49 13.58
LTL to 5YR AVG FCF -0.66 0.21
Shares Outstanding Growth 5YR AVG 44.10% 117.96%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙